Recurrent Adult Diffuse Large Cell Lymphoma: Clinical Trials

2 trials for Recurrent Adult Diffuse Large Cell Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow Recurrent Adult Diffuse Large Cell Lymphoma: new trials by email Literature Review of Recurrent Adult Diffuse Large Cell Lymphoma trials Research Report on Recurrent Adult Diffuse Large Cell Lymphoma

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications
internet-based intervention, questionnaire administration, psychosocial assessment and care - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Phase 3CompletedFred Hutchinson Cancer Research Center/University of Washington Cancer Consortium13372008-08-012012-03-07
Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma
aldesleukin, filgrastim, cyclophosphamide - Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma
Phase 3CompletedNational Cancer Institute (NCI)2061995-05-012013-02-28

Narrower conditions

Burkitt Lymphoma (2)  ·  Lymphoma, Follicular (2)  ·  Lymphoma, Large B-Cell, Diffuse (2)  ·  Lymphoma, Large-Cell, Immunoblastic (2)  ·  Lymphoma, Non-Hodgkin (2)  ·  Blast Crisis (1)  ·  Congenital Abnormalities (1)  ·  Depression (1)  ·  Fatigue (1)  ·  Hodgkin Disease (1)  ·  Leukemia, Hairy Cell (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Leukemia, Myeloid, Accelerated Phase (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative (1)

Broader conditions

DNA Virus Infections (2)  ·  Epstein-Barr Virus Infections (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Herpesviridae Infections (2)  ·  Immune System Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Infections (2)  ·  Lymphatic Diseases (2)  ·  Lymphoma (2)  ·  Lymphoma, B-Cell (2)  ·  Lymphoproliferative Disorders (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Tumor Virus Infections (2)  ·  Virus Diseases (2)

Interventions

Counseling (1)  ·  Cyclophosphamide (1)  ·  Etoposide (1)  ·  Filgrastim (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Interleukin-2 (1)  ·  Peripheral Blood Stem Cell Transplantation (1)  ·  Psychiatric Rehabilitation (1)  ·  Radiation (1)  ·  Radiotherapy (1)  ·  Therapeutics (1)  ·  aldesleukin (1)

Sponsors

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium (1)  ·  National Cancer Institute (NCI) (1)

Countries

United States (2)

Top investigators

John Thompson (1)  ·  Karen Syrjala (1)

Results publications

PMID 18256325, PMID 32628342, PMID 33420905, PMID 36282798

NIH funding

R01CA112631 (1), U10CA032102 (1)